Search Within

Katherine S Panageas

Formats
  1. Journal Article (320)
  2. Meeting Abstract (181)
  3. Editorial (5)
  4. Research Letter (5)
  5. Correspondence (4)
  6. Review (4)
  7. Book Section (3)
  8. Miscellaneous (1)
Groups
  1. Biostatistics Service (523)
  2. Epidemiology and Biostatistics (523)
  3. Population Sciences Research Program (523)
  4. Department of Medicine (306)
  5. Solid Tumor Oncology Division (264)
  6. GSK Faculty (189)

More Groups

People
  1. Anne Reiner (94)
  2. Jedd Wolchok (92)
  3. Lisa De Angelis (86)
  4. Paul Chapman (77)
  5. Michael Postow (66)
  6. Clifford Hudis (56)

More People

Years
  1. 2025 (19)
  2. 2024 (23)
  3. 2023 (28)
  4. 2022 (28)
  5. 2021 (34)
  6. 2020 (29)

More Years

Publications
  1. Journal of Clinical Oncology (109)
  2. Neuro-Oncology (42)
  3. Clinical Cancer Research (31)
  4. Annals of Surgical Oncology (28)
  5. Cancer (21)
  6. Breast Cancer Research and Treatment (20)

More Publications

Publishers
  1. American Society of Clinical Oncology (122)
  2. Oxford University Press (68)
  3. Springer (65)
  4. American Association for Cancer Research (56)
  5. Wiley Blackwell (38)
  6. American Medical Association (19)

More Publishers

Results (523)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The effect of clustering of outcomes on the association of procedure volume and surgical outcomes
    Journal Article

    Panageas, K. S.; Schrag, D.; Riedel, E.; Bach, P. B.; Begg, C. B.
    Annals of Internal Medicine (2003)

    Fulltext@MSK | Save
  • Analysis of multiple 2x2 tables with site-specific periodontal data
    Journal Article

    Panageas, K. S.; Begg, M. D.; Grbic, J. T.; Lamster, I. B.
    Journal of Dental Research (2003)

    Fulltext@MSK | Save
  • Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanoma
    Journal Article

    Hwu, W. J.; Krown, S. E.; Menell, J. H.; Panageas, K. S.; Merrell, J.; Lamb, L. A.; Williams, L. J.; Quinn, C. J.; Foster, T.; Chapman, P. B.; more...
    Journal of Clinical Oncology (2003)

    Fulltext@MSK | Save
  • Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemias
    Journal Article

    Burke, J. M. ; Caron, P. C.; Papadopoulos, E. B.; Divgi, C. R.; Sgouros, G.; Panageas, K. S.; Finn, R. D.; Larson, S. M.; O'Reilly, R. J.; Scheinberg, D. A.; more...
    Bone Marrow Transplantation (2003)

    Fulltext@MSK | Save
  • Ductal lavage in patients undergoing mastectomy for mammary carcinoma: A correlative study
    Journal Article

    Brogi, E.; Robson, M.; Panageas, K. S.; Casadio, C.; Ljung, B. M.; Montgomery, L.
    Cancer (2003)

    Fulltext@MSK | Save
  • Is sentinel lymph node biopsy a predictor of outcome in patients with thick cutaneous melanoma?
    Meeting Abstract

    Ferrone, C. R.; Panageas, K. S.; Brady, M. S.; Coit, D. G.
    Annals of Surgical Oncology (2002)

    Fulltext@MSK | Save
  • Serum creatinine (Cr) values in patients with metastatic breast cancer (MBC) treated with pamidronate (PAM) administered as an intravenous 1 hour infusion (1 h)
    Meeting Abstract

    Van Poznak, C.; Ben-Porat, L.; Panageas, K.; Leone, D.; Seidman, A.; Hudis, C.
    Bone (2002)

    Fulltext@MSK | Save
  • Effects of exemestane and raloxifene on breast density by mammography and MRI in postmenopausal women: Preliminary data from a pilot chemoprevention trial
    Meeting Abstract

    Dickler, M.; Morris, E.; Robson, M.; Choi, J.; Hummer, A.; Panageas, K.; Ballon, D.; Borgen, P.; Norton, L.; Hudis, C.
    Cancer Epidemiology Biomarkers and Prevention (2002)

    Fulltext@MSK | Save
  • Effect of creatinine clearance (CrCl) on patterns of toxicity in breast cancer (BC) patients (pts) age 65 and older receiving adjuvant chemotherapy
    Meeting Abstract

    Hurria, A.; Panageas, K.; Brogan, K.; Norton, L.; Howard, J.; Hudis, C.
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save
  • Serum HER2 extracellular domain (ECD) correlates with HER2 status by immunohistochemistry (IHC) and fluorescent in-situ hybridization (FISH) in metastatic breast cancer (MBC) patients (pts) treated with weekly (W) trastuzumab (H) and paclitaxel (T)
    Meeting Abstract

    Fornier, M. N.; Seidman, A. D.; Schwartz, M. K.; Panageas, K. S.; Norton, L.; Hudis, C. A.
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save